ANDOVER, Mass.–(BUSINESS WIRE)–Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and only cleared and dedicated electrosurgical guidewire system to prevent coronary obstruction in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) for both native aortic stenosis and … [Read more…]

ATCC, industry, government, advocacy, and academic leaders met with NSCEB Commissioners for pivotal discussions on the critical role of authenticated biomaterials in a secure and resilient bioeconomy MANASSAS, Va.–(BUSINESS WIRE)–#Biomanufacturing—ATCC, the world’s premier private, non-profit biological resources and standards organization, hosted an event today, Empowering the Future of Biotechnology Through Trusted Science, with the National … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Graft Versus Host Disease (GvHD) Treatment – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for Graft Versus Host Disease (GvHD) Treatment was valued at US$2.9 Billion in 2024 and is projected to reach US$4.5 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Diagnostic Labs Market With Impact Analysis of US Tariffs (2025 Edition)” report has been added to ResearchAndMarkets.com’s offering. The global Diagnostic Labs Market is driven by several key factors. The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions creates a growing need for diagnostic tests, particularly for early detection … [Read more…]

MINNEAPOLIS–(BUSINESS WIRE)–#CEOAnnouncement—beBright, a doctor-founded, doctor-led dual-specialty support organization focused on integrated pediatric and orthodontic care, today announced the appointment of Kyle Clay as Chief Executive Officer. Kyle, who most recently served as Chief Operating Officer, will lead beBright’s next phase of organic growth and continue advancing the company’s mission to deliver exceptional experiences and life-changing … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 – 2033” report has been added to ResearchAndMarkets.com’s offering. The global peanut allergy treatment market size is expected to reach USD 1.46 billion by … [Read more…]

CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that following the announcement on November 14, 2025 of the entering into of a definitive arrangement agreement with XenoTherapeutics, Inc. and Xeno Acquisition Corp. (jointly, “Xeno”), a non-profit biotechnology company, pursuant to which Xeno will … [Read more…]

GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 am Eastern Time (ET). A live audio … [Read more…]

Boston startup – known for pioneering quantum chemistry reformulations to simulate complex drug-protein interactions at a subatomic level with high precision and 1000x faster – raises financing and introduces QUELO v2.3 BOSTON–(BUSINESS WIRE)–QSimulate (www.qsimulate.com) today announced an additional round of seed financing that will bring its total funding to date to over $11 million from … [Read more…]

Recognition reflects company’s emphasis on inclusive culture across global operations and focus on professional growth and development VIENNA–(BUSINESS WIRE)–Ribbon Bio GmbH, the DNA synthesis company, has been named A Best Place to Work 2025 by GenomeWeb in the mid-size category of 51-100 employees. This recognition reflects Ribbon’s commitment to openness, inclusion and transparency, as well … [Read more…]